CoChat

Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

We have shown previously that the camptothecin analogue topotecan (TPT), a topoisomerase I (Top 1) poison, inhibits hypoxia-inducible factor 1 (HIF-1) transcriptional activity and HIF-1α protein accumulation in hypoxia-treated U251 human glioma cells. In this article, we demonstrate that TPT does not affect HIF-1α protein half-life or mRNA accumulation but inhibits its translation. In addition, we demonstrate that Top 1 is required for the inhibition of HIF-1α protein accumulation by TPT as shown by experiments performed using camptothecin-resistant cell lines with known Top 1 alterations. Experiments performed with aphidicolin indicated that TPT inhibited HIF-1 protein accumulation in the absence of DNA replication. DNA-damaging agents, such as ionizing radiation and doxorubicin, did not affect HIF-1α protein accumulation. Ongoing transcription was essential for the inhibition of HIF-1α protein accumulation by TPT. Our results demonstrate the existence of a novel pathway connecting Top 1-dependent signaling events and the regulation of HIF-1α protein expression and function. In addition, our findings dissociate the cytotoxic activity of TPT from the inhibition of the HIF-1 pathway and raise the possibility of novel clinical applications of TPT aimed at targeting HIF-1-dependent responses.

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-03-3139

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 50 references

Cited by

See all 339

Metadata

Authors
Rapisarda, A., Uranchimeg, B., Sordet, O., Pommier, Y., Shoemaker, R. H., & Melillo, G.
Affiliations
  • Frederick National Laboratory for Cancer Research (US)
  • National Cancer Institute (US)
  • 1Developmental Therapeutics Program,
Venue
Cancer Research
Published
2004-02-15
Volume
64
Issue
4
Pages
1475-1482
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2057366549
Cited by
301
References
49
Citations by year
2026: 3 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 5 · 2021: 13 · 2020: 13 · 2019: 14 · 2018: 8 · 2017: 12 · 2016: 12 · 2015: 19 · 2014: 12 · 2013: 11 · 2012: 18
FWCI
8.17
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (n01co12400-79-0-22)
  • National Cancer Institute (N01CO12400)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer therapeutics and mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Keywords
topotecan, topoisomerase I, HIF-1, HIF-1α, transcriptional regulation, camptothecin resistance, U251 cells, ionizing radiation, doxorubicin
MeSH terms
Cysteine Endopeptidases, DNA Damage, DNA Replication, DNA Topoisomerases, Type I, Dose-Response Relationship, Drug, Humans, Multienzyme Complexes, Protein Kinases, Proto-Oncogene Proteins, RNA, Messenger, Transcription Factors, Transcription, Genetic, Protein Biosynthesis, Protein Serine-Threonine Kinases, Topotecan, Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Proteasome Endopeptidase Complex, Proto-Oncogene Proteins c-akt, Hypoxia-Inducible Factor 1, alpha Subunit, TOR Serine-Threonine Kinases, Topoisomerase I Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1. https://app.cochat.ai/papers/10.1158/0008-5472.can-03-3139
The paper
Rapisarda, A., Uranchimeg, B., Sordet, O., Pommier, Y., Shoemaker, R. H., & Melillo, G. (2004). Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1. Cancer Research. https://doi.org/10.1158/0008-5472.can-03-3139

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.